Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by skiboard09on Jun 17, 2019 12:49am

75 Views

Post# 29831030

RE:RE:RE:RE:RE:RE:RE:RE:RE:CHART

If poetically read the last NR and messaged the company. This was a positive NR. The market was confused because it was poorly written and executed. But this is all more positive news.

We we are approved for higher concentration trials. = positive
opens up more markets = positive.
Sirona or partner can do testing = positive.

The new new director with China ties and business experience = positive.

Paitence is a viture. People who have it will be rewarded imho

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario